Paramyxovirus Glycoproteins and the Membrane Fusion Process

Current Clinical Microbiology Reports

Volumn 3, Issue 3, 2016, Pages 142-154

  Aguilar, Hector C ^a   Henderson, Bryce A ^a   Zamora, J Lizbeth ^a   Johnston, Gunner P ^a  

^a WASHINGTON STATE UNIVERSITY   (United States)

Author keywords

Association model; Attachment; Attachment glycoprotein; Dissociation model; F triggering; Fusion; Fusion cascade; Fusion glycoprotein; Fusion model; Fusion pore formation; Hemifusion; Hendra; Hexamer of trimers; hMPV; Measles; Membrane fusion; Mumps; NDV; Nipah; Paramyxoviridae; Paramyxovirus; Post fusion; Pre fusion; Pre hairpin intermediate; RSV; Syncytia; Viral entry; Viral receptors

Indexed keywords

EID: 85018326194     PISSN: None     EISSN: 21965471     Source Type: Journal    
DOI: 10.1007/s40588-016-0040-8     Document Type: Review

References (168)

1. Bossart KN, Fusco DL, Broder CC. Paramyxovirus entry. Viral Entry into Host Cells. 2013;790:95–127.
2. Chang A, Dutch RE. Paramyxovirus fusion and entry: multiple paths to a common end. Viruses. 2012;4:613–36.
3. Enders G. Paramyxoviruses. In: Baron S, editor. Medical microbiology, 4th ed, Galveston, TX: University of Texas Medical Branch; 1996
4. Ching PK, de los Reyes VC, Sucaldito MN, Tayag E, Columna-Vingno AB, Malbas Jr FF, et al. Outbreak of henipavirus infection, Philippines, 2014. Emerg Infect Dis. 2015;21:328–31.
5. Goh KJ, Tan CT, Chew NK, Tan PS, Kamarulzaman A, Sarji SA, et al. Clinical features of Nipah virus encephalitis among pig farmers in Malaysia. N Engl J Med. 2000;342:1229–35.
6. Harit AK, Ichhpujani SG, Gill KS, Lal S, Ganguly NK, Agarwal SP. Nipah/Hendra virus outbreak in Siliguri, West Bengal, India in 2001. Indian J Med Res. 2006;123:553–60.
7. Hossain MJ, Gurley ES, Montgomery JM, Bell M, Carroll DS, Hsu VP, et al. Clinical presentation of Nipah virus infection in Bangladesh. Clin Infect Dis. 2008;46:977–84.
8. Luby SP, Hossain MJ, Gurley ES, Ahmed BN, Banu S, Khan SU, et al. Recurrent zoonotic transmission of Nipah virus into humans, Bangladesh, 2001–2007. Emerg Infect Dis. 2009;15:1229–35.
9. Parashar UD, Sunn LM, Ong F, Mounts AW, Arif MT, Ksiazek TG, et al. Case-control study of risk factors for human infection with the new zoonotic paramyxoviruses, Nipah virus, during a 1998–1999 outbreak of severe encephalitis in Malaysia. J Infect Dis. 2000;181:1755–9.
10. Drexler JF, Corman VM, Gloza-Rausch F, Seebens A, Annan A, Ipsen A, et al. Henipavirus RNA in African bats. PLoS One. 2009;4, e6367.
11. Peel AJ, Baker KS, Crameri G, Barr JA, Hayman DT, Wright E, et al. Henipavirus neutralising antibodies in an isolated island population of African fruit bats. PLoS One. 2012;7, e30346.
12. Pernet O, Schneider BS, Beaty SM, LeBreton M, Yun TE, Park A, et al. Evidence for henipavirus spillover into human populations in Africa. Nat Commun. 2014;5:5342
13. Drexler JF, Corman VM, Muller MA, Maganga GD, Vallo P, Binger T, et al. Bats host major mammalian paramyxoviruses. Nat Commun. 2012;3:796. This study surveyed approximately 5,000 bat samples from several bat species across continents and has led to the discoveries of novel Paramyxoviruses in South America and Africa.
14. Falk K, Batts WN, Kvellestad A, Kurath G, Wiik-Nielsen J, Winton JR. Molecular characterisation of Atlantic salmon paramyxovirus (ASPV): a novel paramyxovirus associated with proliferative gill inflammation. Virus Res. 2008;133:218–27.
15. Kurath G, Batts WN, Ahne W, Winton JR. Complete genome sequence of Fer-de-Lance virus reveals a novel gene in reptilian paramyxoviruses. J Virol. 2004;78:2045–56.
16. Basler CF, Garcia-Sastre A, Palese P. A novel paramyxovirus? Emerg Infect Dis. 2005;11:108–12.
17. Magoffin DE, Mackenzie JS, Wang LF. Genetic analysis of J-virus and Beilong virus using minireplicons. Virology. 2007;364:103–11.
18. Woo PC, Lau SK, Wong BH, Wong AY, Poon RW, Yuen KY. Complete genome sequence of a novel paramyxovirus, Tailam virus, discovered in Sikkim rats. J Virol. 2011;85:13473–4.
19. Adamson P, Thammawat S, Muchondo G, Sadlon T, Gordon D. Diversity in glycosaminoglycan binding amongst hMPV G protein lineages. Viruses. 2012;4:3785–803.
20. Biacchesi S, Pham QN, Skiadopoulos MH, Murphy BR, Collins PL, Buchholz UJ. Infection of nonhuman primates with recombinant human metapneumovirus lacking the SH, G, or M2-2 protein categorizes each as a nonessential accessory protein and identifies vaccine candidates. J Virol. 2005;79:12608–13.
21. Bose S, Welch BD, Kors CA, Yuan P, Jardetzky TS, Lamb RA. Structure and mutagenesis of the parainfluenza virus 5 hemagglutinin-neuraminidase stalk domain reveals a four-helix bundle and the role of the stalk in fusion promotion. J Virol. 2011;85:12855–66.
22. Chang A, Masante C, Buchholz UJ, Dutch RE. Human metapneumovirus (HMPV) binding and infection are mediated by interactions between the HMPV fusion protein and heparan sulfate. J Virol. 2012;86:3230–43.
23. Lee B, Pernet O, Ahmed AA, Zeltina A, Beaty SM, Bowden TA. Molecular recognition of human ephrinB2 cell surface receptor by an emergent African henipavirus. Proc Natl Acad Sci U S A. 2015;112:E2156–65.
24. Yuan P, Leser GP, Demeler B, Lamb RA, Jardetzky TS. Domain architecture and oligomerization properties of the paramyxovirus PIV 5 hemagglutinin-neuraminidase (HN) protein. Virology. 2008;378:282–91.
25. Yuan P, Swanson KA, Leser GP, Paterson RG, Lamb RA, Jardetzky TS. Structure of the Newcastle disease virus hemagglutinin-neuraminidase (HN) ectodomain reveals a four-helix bundle stalk. Proc Natl Acad Sci U S A. 2011;108:14920–5. This study offered the first structural understanding of an attachment glycoprotein stalk. Since the stalk is often associated with F-triggering, structural data is valuable to gain insight into this process.
26. Yuan P, Thompson TB, Wurzburg BA, Paterson RG, Lamb RA, Jardetzky TS. Structural studies of the parainfluenza virus 5 hemagglutinin-neuraminidase tetramer in complex with its receptor, sialyllactose. Structure. 2005;13:803–15.
27. Aguilar HC, Iorio RM. Henipavirus membrane fusion and viral entry. Curr Top Microbiol Immunol. 2012;359:79–94.
28. Crennell S, Takimoto T, Portner A, Taylor G. Crystal structure of the multifunctional paramyxovirus hemagglutinin-neuraminidase. Nat Struct Biol. 2000;7:1068–74.
29. Iorio RM, Field GM, Sauvron JM, Mirza AM, Deng R, Mahon PJ, et al. Structural and functional relationship between the receptor recognition and neuraminidase activities of the Newcastle disease virus hemagglutinin-neuraminidase protein: receptor recognition is dependent on neuraminidase activity. J Virol. 2001;75:1918–27.
30. Iorio RM, Glickman RL, Sheehan JP. Inhibition of fusion by neutralizing monoclonal antibodies to the haemagglutinin-neuraminidase glycoprotein of Newcastle disease virus. The Journal of general virology. 1992;73(Pt 5):1167–76.
31. Iorio RM, Mahon PJ. Paramyxoviruses: different receptors—different mechanisms of fusion. Trends Microbiol. 2008;16:135–7.
32. Iorio RM, Melanson VR, Mahon PJ. Glycoprotein interactions in paramyxovirus fusion. Future Virol. 2009;4:335–51.
33. Dutch RE, Joshi SB, Lamb RA. Membrane fusion promoted by increasing surface densities of the paramyxovirus F and HN proteins: comparison of fusion reactions mediated by simian virus 5 F, human parainfluenza virus type 3 F, and influenza HA. J Virol. 1998;72:7745–53.
34. Santiago C, Celma ML, Stehle T, Casasnovas JM. Structure of the measles virus hemagglutinin bound to the CD46 receptor. Nat Struct Mol Biol. 2010;17:124–9.
35. Brindley MA, Plemper RK. Blue native PAGE and biomolecular complementation reveal a tetrameric or higher-order oligomer organization of the physiological measles virus attachment protein H. J Virol. 2010;84:12174–84.
36. Hashiguchi T, Ose T, Kubota M, Maita N, Kamishikiryo J, Maenaka K, et al. Structure of the measles virus hemagglutinin bound to its cellular receptor SLAM. Nat Struct Mol Biol. 2011;18:135–41.
37. Khosravi M, Bringolf F, Rothlisberger S, Bieringer M, Schneider-Schaulies J, Zurbriggen A, et al. Canine distemper virus fusion activation: critical role of residue E123 of CD150/SLAM. J Virol. 2016;90:1622–37.
38. Melia MM, Earle JP, Abdullah H, Reaney K, Tangy F, Cosby SL. Use of SLAM and PVRL4 and identification of pro-HB-EGF as cell entry receptors for wild type phocine distemper virus. PLoS One. 2014;9, e106281.
39. Muhlebach MD, Mateo M, Sinn PL, Prufer S, Uhlig KM, Leonard VH, et al. Adherens junction protein nectin-4 is the epithelial receptor for measles virus. Nature. 2011. doi:10.1038/nature10639.
40. Noyce RS, Bondre DG, Ha MN, Lin LT, Sisson G, Tsao MS, et al. Tumor cell marker PVRL4 (nectin 4) is an epithelial cell receptor for measles virus. PLoS Pathog. 2011;7, e1002240.
41. Noyce RS, Richardson CD. Nectin 4 is the epithelial cell receptor for measles virus. Trends Microbiol. 2012;20:429–39.
42. Sellin CI, Davoust N, Guillaume V, Baas D, Belin MF, Buckland R, et al. High pathogenicity of wild-type measles virus infection in CD150 (SLAM) transgenic mice. J Virol. 2006;80:6420–9.
43. Welstead GG, Hsu EC, Iorio C, Bolotiin S, Richardson CD. Mechanism of CD150 (SLAM) down regulation from the host cell surface by measles virus hemagglutinin protein. J Virol. 2004;78:9666–74.
44. Tayyari F, Marchant D, Moraes TJ, Duan W, Mastrangelo P, Hegele RG. Identification of nucleolin as a cellular receptor for human respiratory syncytial virus. Nat Med. 2011;17:1132–5.
45. Behera AK, Matsuse H, Kumar M, Kong X, Lockey RF, Mohapatra SS. Blocking intercellular adhesion molecule-1 on human epithelial cells decreases respiratory syncytial virus infection. Biochem Biophys Res Commun. 2001;280:188–95.
46. Schildgen V, van den Hoogen B, Fouchier R, Tripp RA, Alvarez R, Manoha C, et al. Human metapneumovirus: lessons learned over the first decade. Clin Microbiol Rev. 2011;24:734–54.
47. Schowalter RM, Chang A, Robach JG, Buchholz UJ, Dutch RE. Low-pH triggering of human metapneumovirus fusion: essential residues and importance in entry. J Virol. 2009;83:1511–22.
48. Thammawat S, Sadlon TA, Hallsworth PG, Gordon DL. Role of cellular glycosaminoglycans and charged regions of viral G protein in human metapneumovirus infection. J Virol. 2008;82:11767–74.
49. van Bleek GM, Osterhaus AD, de Swart RL. RSV 2010: recent advances in research on respiratory syncytial virus and other pneumoviruses. Vaccine. 2011;29:7285–91.
50. Aguilar HC, Ataman ZA, Aspericueta V, Fang AQ, Stroud M, Negrete OA, et al. A novel receptor-induced activation site in the Nipah virus attachment glycoprotein (G) involved in triggering the fusion glycoprotein (F). J Biol Chem. 2009;284:1628–35.
51. Bonaparte MI, Dimitrov AS, Bossart KN, Crameri G, Mungall BA, Bishop KA, et al. Ephrin-B2 ligand is a functional receptor for Hendra virus and Nipah virus. Proc Natl Acad Sci U S A. 2005;102:10652–7.
52. Bowden TA, Aricescu AR, Gilbert RJ, Grimes JM, Jones EY, Stuart DI. Structural basis of Nipah and Hendra virus attachment to their cell-surface receptor ephrin-B2. Nat Struct Mol Biol. 2008;15:567–72.
53. Bowden TA, Crispin M, Harvey DJ, Aricescu AR, Grimes JM, Jones EY, et al. Crystal structure and carbohydrate analysis of Nipah virus attachment glycoprotein: a template for antiviral and vaccine design. J Virol. 2008;82:11628–36.
54. Marsh GA, de Jong C, Barr JA, Tachedjian M, Smith C, Middleton D, et al. Cedar virus: a novel Henipavirus isolated from Australian bats. PLoS Pathog. 2012;8, e1002836.
55. Negrete OA, Chu D, Aguilar HC, Lee B. Single amino acid changes in the Nipah and Hendra virus attachment glycoproteins distinguish ephrinB2 from ephrinB3 usage. J Virol. 2007;81:10804–14.
56. Negrete OA, Levroney EL, Aguilar HC, Bertolotti-Ciarlet A, Nazarian R, Tajyar S, et al. EphrinB2 is the entry receptor for Nipah virus, an emergent deadly paramyxovirus. Nature. 2005;436:401–5.
57. Negrete OA, Wolf MC, Aguilar HC, Enterlein S, Wang W, Muhlberger E, et al. Two key residues in ephrinB3 are critical for its use as an alternative receptor for Nipah virus. PLoS Pathog. 2006;2, e7.
58. Karron RA, Buonagurio DA, Georgiu AF, Whitehead SS, Adamus JE, Clements-Mann ML, et al. Respiratory syncytial virus (RSV) SH and G proteins are not essential for viral replication in vitro: clinical evaluation and molecular characterization of a cold-passaged, attenuated RSV subgroup B mutant. Proc Natl Acad Sci U S A. 1997;94:13961–6.
59. Kahn JS, Schnell MJ, Buonocore L, Rose JK. Recombinant vesicular stomatitis virus expressing respiratory syncytial virus (RSV) glycoproteins: RSV fusion protein can mediate infection and cell fusion. Virology. 1999;254:81–91.
60. Karger A, Schmidt U, Buchholz UJ. Recombinant bovine respiratory syncytial virus with deletions of the G or SH genes: G and F proteins bind heparin. J Gen Virol. 2001;82:631–40.
61. Leyrer S, Bitzer M, Lauer U, Kramer J, Neubert WJ, Sedlmeier R. Sendai virus-like particles devoid of haemagglutinin-neuraminidase protein infect cells via the human asialoglycoprotein receptor. J Gen Virol. 1998;79(Pt 4):683–7.
62. Aleksandrowicz P, Marzi A, Biedenkopf N, Beimforde N, Becker S, Hoenen T, et al. Ebola virus enters host cells by macropinocytosis and clathrin-mediated endocytosis. J Infect Dis. 2011;204 Suppl 3:S957–67.
63. Sakurai Y, Kolokoltsov AA, Chen C, Tidwell MW, Bauta WE, Klugbauer N, et al. Two-pore channels control Ebola virus host cell entry and are drug targets for disease treatment. Science. 2015;347:995–8.
64. Lakadamyali M, Rust MJ, Zhuang X. Endocytosis of influenza viruses. Microbes Infect. 2004;6:929–36.
65. Berghall H, Wallen C, Hyypia T, Vainionpaa R. Role of cytoskeleton components in measles virus replication. Arch Virol. 2004;149:891–901.
66. Bohn W, Ciampor F, Rutter R, Mannweiler K. Localization of nucleocapsid associated polypeptides in measles virus-infected cells by immunogold labelling after resin embedding. Arch Virol. 1990;114:53–64.
67. Bowden TA, Crispin M, Harvey DJ, Jones EY, Stuart DI. Dimeric architecture of the Hendra virus attachment glycoprotein: evidence for a conserved mode of assembly. J Virol. 2010;84:6208–17.
68. Campbell SM, Crowe SM, Mak J. Lipid rafts and HIV-1: from viral entry to assembly of progeny virions. J Clin Virol. 2001;22:217–27.
69. Ciancanelli MJ, Basler CF. Mutation of YMYL in the Nipah virus matrix protein abrogates budding and alters subcellular localization. J Virol. 2006;80:12070–8.
70. Coronel EC, Murti KG, Takimoto T, Portner A. Human parainfluenza virus type 1 matrix and nucleoprotein genes transiently expressed in mammalian cells induce the release of virus-like particles containing nucleocapsid-like structures. J Virol. 1999;73:7035–8.
71. Horvath CM, Paterson RG, Shaughnessy MA, Wood R, Lamb RA. Biological activity of paramyxovirus fusion proteins: factors influencing formation of syncytia. J Virol. 1992;66:4564–9.
72. Kruger N, Hoffmann M, Weis M, Drexler JF, Muller MA, Winter C, et al. Surface glycoproteins of an African henipavirus induce syncytium formation in a cell line derived from an African fruit bat, Hypsignathus monstrosus. J Virol. 2013;87:13889–91.
73. Okamoto K, Ohgimoto S, Nishio M, Tsurudome M, Kawano M, Komada H, et al. Paramyxovirus-induced syncytium cell formation is suppressed by a dominant negative fusion regulatory protein-1 (FRP-1)/CD98 mutated construct: an important role of FRP-1 in virus-induced cell fusion. J Gen Virol. 1997;78:775–83.
74. Wong KT, Shieh WJ, Kumar S, Norain K, Abdullah W, Guarner J, et al. Nipah virus infection: pathology and pathogenesis of an emerging paramyxoviral zoonosis. Am J Pathol. 2002;161:2153–67.
75. Merz DC, Scheid A, Choppin PW. Importance of antibodies to the fusion glycoprotein of paramyxoviruses in the prevention of spread of infection. J Exp Med. 1980;151:275–88.
76. Habchi J, Longhi S. Structural disorder within paramyxoviral nucleoproteins and phosphoproteins in their free and bound forms: from predictions to experimental assessment. Int J Mol Sci. 2015;16:15688–726.
77. Harcourt BH, Tamin A, Ksiazek TG, Rollin PE, Anderson LJ, Bellini WJ, et al. Molecular characterization of Nipah virus, a newly emergent paramyxovirus. Virology. 2000;271:334–49.
78. Loney C, Mottet-Osman G, Roux L, Bhella D. Paramyxovirus ultrastructure and genome packaging: cryo-electron tomography of Sendai virus. J Virol. 2009;83:8191–7.
79. Pantua HD, McGinnes LW, Peeples ME, Morrison TG. Requirements for the assembly and release of Newcastle disease virus-like particles. J Virol. 2006;80:11062–73.
80. Ray G, Schmitt PT, Schmitt AP. C-terminal DxD-containing sequences within paramyxovirus nucleocapsid proteins determine matrix protein compatibility and can direct foreign proteins into budding particles. J Virol. 2016;90:3650–60.
81. Prescott J, de Wit E, Feldmann H, Munster VJ. The immune response to Nipah virus infection. Arch Virol. 2012;157:1635–41.
82. Childs K, Stock N, Ross C, Andrejeva J, Hilton L, Skinner M, et al. mda-5, but not RIG-I, is a common target for paramyxovirus V proteins. Virology. 2007;359:190–200.
83. Horikami SM, Hector RE, Smallwood S, Moyer SA. The Sendai virus C protein binds the L polymerase protein to inhibit viral RNA synthesis. Virology. 1997;235:261–70.
84. Kato A, Ohnishi Y, Kohase M, Saito S, Tashiro M, Nagai Y. Y2, the smallest of the Sendai virus C proteins, is fully capable of both counteracting the antiviral action of interferons and inhibiting viral RNA synthesis. J Virol. 2001;75:3802–10.
85. Lu LL, Puri M, Horvath CM, Sen GC. Select paramyxoviral V proteins inhibit IRF3 activation by acting as alternative substrates for inhibitor of kappaB kinase epsilon (IKKe)/TBK1. J Biol Chem. 2008;283:14269–76.
86. Parisien JP, Bamming D, Komuro A, Ramachandran A, Rodriguez JJ, Barber G, et al. A shared interface mediates paramyxovirus interference with antiviral RNA helicases MDA5 and LGP2. J Virol. 2009;83:7252–60.
87. Patterson JB, Thomas D, Lewicki H, Billeter MA, Oldstone MB. V and C proteins of measles virus function as virulence factors in vivo. Virology. 2000;267:80–9.
88. Audsley MD, Moseley GW. Paramyxovirus evasion of innate immunity: diverse strategies for common targets. World J Virol. 2013;2:57–70.
89. Harrison MS, Sakaguchi T, Schmitt AP. Paramyxovirus assembly and budding: building particles that transmit infections. Int J Biochem Cell Biol. 2010;42:1416–29.
90. Patch JR, Han Z, McCarthy SE, Yan L, Wang LF, Harty RN, et al. The YPLGVG sequence of the Nipah virus matrix protein is required for budding. Virol J. 2008;5:137.
91. Pohl C, Duprex WP, Krohne G, Rima BK, Schneider-Schaulies S. Measles virus M and F proteins associate with detergent-resistant membrane fractions and promote formation of virus-like particles. J Gen Virol. 2007;88:1243–50.
92. Schmitt AP, Leser GP, Morita E, Sundquist WI, Lamb RA. Evidence for a new viral late-domain core sequence, FPIV, necessary for budding of a paramyxovirus. J Virol. 2005;79:2988–97.
93. Schmitt AP, Leser GP, Waning DL, Lamb RA. Requirements for budding of paramyxovirus simian virus 5 virus-like particles. J Virol. 2002;76:3952–64.
94. Takimoto T, Murti KG, Bousse T, Scroggs RA, Portner A. Role of matrix and fusion proteins in budding of Sendai virus. J Virol. 2001;75:11384–91.
95. Takimoto T, Portner A. Molecular mechanism of paramyxovirus budding. Virus Res. 2004;106:133–45.
96. Ader N, Brindley MA, Avila M, Origgi FC, Langedijk JP, Orvell C, et al. Structural rearrangements of the central region of the morbillivirus attachment protein stalk domain trigger F protein refolding for membrane fusion. J Biol Chem. 2012;287:16324–34.
97. Liu Q, Stone JA, Bradel-Tretheway B, Dabundo J, Benavides Montano JA, Santos-Montanez J, et al. Unraveling a three-step spatiotemporal mechanism of triggering of receptor-induced Nipah virus fusion and cell entry. PLoS Pathog. 2013;9, e1003770.
98. Ader-Ebert N, Khosravi M, Herren M, Avila M, Alves L, Bringolf F, et al. Sequential conformational changes in the morbillivirus attachment protein initiate the membrane fusion process. PLoS Pathog. 2015;11(5):e1004880.
99. Bishop KA, Hickey AC, Khetawat D, Patch JR, Bossart KN, Zhu Z, et al. Residues in the stalk domain of the Hendra virus G glycoprotein modulate conformational changes associated with receptor binding. J Virol. 2008;82:11398–409.
100. Bose S, Song AS, Jardetzky TS, Lamb RA. Fusion activation through attachment protein stalk domains indicates a conserved core mechanism of paramyxovirus entry into cells. J Virol. 2014;88:3925–41.
101. Bose S, Zokarkar A, Welch BD, Leser GP, Jardetzky TS, Lamb RA. Fusion activation by a headless parainfluenza virus 5 hemagglutinin-neuraminidase stalk suggests a modular mechanism for triggering. Proc Natl Acad Sci U S A. 2012;109:E2625–34.
102. Brindley MA, Suter R, Schestak I, Kiss G, Wright ER, Plemper RK. A stabilized headless measles virus attachment protein stalk efficiently triggers membrane fusion. Journal of Virology 2013 In Press.
103. Melanson VR, Iorio RM. Amino acid substitutions in the F-specific domain in the stalk of the Newcastle disease virus HN protein modulate fusion and interfere with its interaction with the F protein. J Virol. 2004;78:13053–61.
104. Navaratnarajah CK, Negi S, Braun W, Cattaneo R. Membrane fusion triggering: three modules with different structure and function in the upper half of the measles virus attachment protein stalk. J Biol Chem. 2012;287:38543–51.
105. Lou Z, Xu Y, Xiang K, Su N, Qin L, Li X, et al. Crystal structures of Nipah and Hendra virus fusion core proteins. Febs J. 2006;273:4538–47.
106. Matthews JM, Young TF, Tucker SP, Mackay JP. The core of the respiratory syncytial virus fusion protein is a trimeric coiled coil. J Virol. 2000;74:5911–20.
107. Welch BD, Liu Y, Kors CA, Leser GP, Jardetzky TS, Lamb RA. Structure of the cleavage-activated prefusion form of the parainfluenza virus 5 fusion protein. Proc Natl Acad Sci U S A. 2012;109:166672–7.
108. White JM, Delos SE, Brecher M, Schornberg K. Structures and mechanisms of viral membrane fusion proteins: multiple variations on a common theme. Crit Rev Biochem Mol Biol. 2008;43:189–219.
109. Wong JJ, Paterson RG, Lamb RA, Jardetzky TS. Structure and stabilization of the Hendra virus F glycoprotein in its prefusion form. Proc Natl Acad Sci U S A. 2016;113:1056–61.
110. Xu K, Chan YP, Bradel-Tretheway B, Akyol-Ataman Z, Zhu Y, Dutta S, et al. Crystal structure of the pre-fusion Nipah virus fusion glycoprotein reveals a novel hexamer-of-trimers assembly. PLoS Pathog. 2015;11, e1005322. This study showed that host-cell invasion may be a more coordinated task than previously anticipated. In prior publications, our understanding of membrane fusion has been quite two dimensional, and involved only one or two fusion protein trimers.
111. Yin HS, Wen X, Paterson RG, Lamb RA, Jardetzky TS. Structure of the parainfluenza virus 5 F protein in its metastable, prefusion conformation. Nature. 2006;439:38–44.
112. Bossart KN, Wang LF, Eaton BT, Broder CC. Functional expression and membrane fusion tropism of the envelope glycoproteins of Hendra virus. Virology. 2001;290:121–35.
113. Krzyzaniak MA, Zumstein MT, Gerez JA, Picotti P, Helenius A. Host cell entry of respiratory syncytial virus involves macropinocytosis followed by proteolytic activation of the F protein. PLoS Pathog. 2013;9(4):e1003309.
114. Bolt G, Pederson LO, Birkeslund HH. Cleavage of the respiratory syncytial virus fusion protein is required for its surface expression: role of furin. Virus Res. 2000;68:25–33.
115. Sakaguchi T, Fujii Y, Kiyotani K, Yoshida T. Correlation of proteolytic cleavage of F protein precursors in paramyxoviruses with expression of the fur, PACE4, and PC6 genes in mammalian cells. J Gen Virol. 1994;75:2821–7.
116. Xu Y, Gao S, Cole DK, Zhu J, Su N, Wang H, et al. Basis for fusion inhibition by peptides: analysis of the heptad repeat regions of the fusion proteins from Nipah and Hendra viruses, newly emergent zoonotic paramyxoviruses. Biochem Biophys Res Commun. 2004;315:664–70.
117. Xu Y, Lou Z, Liu Y, Cole DK, Su N, Qin L, et al. Crystallization and preliminary crystallographic analysis of the fusion core from two new zoonotic paramyxoviruses, Nipah virus and Hendra virus. Acta Crystallogr D Biol Crystallogr. 2004;60:1161–4.
118. Lambert DM, Barney S, Lambert AL, Guthrie K, Medinas R, Davis DE, et al. Peptides from conserved regions of paramyxovirus fusion (F) proteins are potent inhibitors of viral fusion. Proc Natl Acad Sci U S A. 1996;93:2186–91.
119. Yin HS, Paterson RG, Wen X, Lamb RA, Jardetzky TS. Structure of the uncleaved ectodomain of the paramyxovirus (hPIV3) fusion protein. Proc Natl Acad Sci U S A. 2005;102:9288–93.
120. Gardner AE, Dutch RE. A conserved region in the F(2) subunit of paramyxovirus fusion proteins is involved in fusion regulation. J Virol. 2007;81:8303–14.
121. Hashiguchi T, Kajikawa M, Maita N, Takeda M, Kuroki K, Sasaki K, et al. Crystal structure of measles virus hemagglutinin provides insight into effective vaccines. Proc Natl Acad Sci U S A. 2007;104:19535–40.
122. Lawrence MC, Borg NA, Streltsov VA, Pilling PA, Epa VC, Varghese JN, et al. Structure of the haemagglutinin-neuraminidase from human parainfluenza virus type III. J Mol Biol. 2004;335:1343–57.
123. Hashiguchi T, Maenaka K, Yanagi Y. Measles virus hemagglutinin: structural insights into cell entry and measles vaccine. Front Microbiol. 2011;2:247.
124. Plemper RK, Brindley MA, Iorio RM. Structural and mechanistic studies of measles virus illuminate paramyxovirus entry. PLoS Pathog. 2011;7, e1002058.
125. Navaratnarajah CK, Oezguen N, Rupp L, Kay L, Leonard VH, Braun W, et al. The heads of the measles virus attachment protein move to transmit the fusion-triggering signal. Nat Struct Mol Biol. 2011;18:128–34.
126. Gravel KA, Morrison TG. Interacting domains of the HN and F proteins of Newcastle disease virus. J Virol. 2003;77:11040–9.
127. Lee JK, Prussi A, Paal T, White LK, Snyder JP, Plemper RK. Functional interaction between paramyxovirus fusion and attachment proteins. J Biol Chem. 2008;283:16561–72.
128. Chen L, Gorman JJ, McKimm-Breschkin J, Lawrence LJ, Tulloch PA, Smith BJ, et al. The structure of the fusion glycoprotein of Newcastle disease virus suggests a novel paradigm for the molecular mechanism of membrane fusion. Structure (Camb). 2001;9:255–66.
129. Kim YH, Donald JE, Grigoryan G, Leser GP, Fadeev AY, Lamb RA, et al. Capture and imaging of a prehairpin fusion intermediate of the paramyxovirus PIV5. Proc Natl Acad Sci U S A. 2011;108:20992–7.
130. McLellan JS, Yang YP, Graham BS, Kwong PD. Structure of respiratory syncytial virus fusion glycoprotein in the postfusion conformation reveals preservation of neutralizing epitopes. J Virol. 2011;85:7788–96.
131. Swanson K, Wen XL, Leser GP, Paterson RG, Lamb RA, Jardetzky TS. Structure of the Newcastle disease virus F protein in the post-fusion conformation. Virology. 2010;402:372–9.
132. Zhao X, Singh M, Malashkevich VN, Kim PS. Structural characterization of the human respiratory syncytial virus fusion protein core. Proc Natl Acad Sci U S A. 2000;97:14172–7.
133. Dutch RE. Entry and fusion of emerging paramyxoviruses. PLoS Pathog. 2010;6, e1000881.
134. Lamb RA, Jardetzky TS. Structural basis of viral invasion: lessons from paramyxovirus F. Curr Opin Struct Biol. 2007;17:427–36.
135. Aguilar HC, Matreyek KA, Choi DY, Filone CM, Young S, Lee B. Polybasic KKR motif in the cytoplasmic tail of Nipah virus fusion protein modulates membrane fusion by inside-out signaling. J Virol. 2007;81:4520–32.
136. Aguilar HC, Matreyek KA, Filone CM, Hashimi ST, Levroney EL, Negrete OA, et al. N-glycans on Nipah virus fusion protein protect against neutralization but reduce membrane fusion and viral entry. J Virol. 2006;80:4878–89.
137. Bishop KA, Stantchev TS, Hickey AC, Khetawat D, Bossart KN, Krasnoperov V, et al. Identification of Hendra virus G glycoprotein residues that are critical for receptor binding. J Virol. 2007;81:5893–901.
138. Corey EA, Iorio RM. Mutations in the stalk of the measles virus hemagglutinin protein decrease fusion but do not interfere with virus-specific interaction with the homologous fusion protein. J Virol. 2007;81:9900–10.
139. Plemper RK, Hammond AL, Gerlier D, Fielding AK, Cattaneo R. Strength of envelope protein interaction modulates cytopathicity of measles virus. J Virol. 2002;76:5051–61.
140. Talekar A, Moscona A, Porotto M. Measles virus fusion machinery activated by sialic acid binding globular domain. J Virol. 2013;87:13619–27.
141. Bose S, Jardetzky TS, Lamb RA. Timing is everything: fine-tuned molecular machines orchestrate paramyxovirus entry. Virology. 2015;479:518–31.
142. Brindley MA, Chaudhury S, Plemper RK. Measles virus glycoprotein complexes preassemble intracellularly and relax during transport to the cell surface in preparation for fusion. J Virol. 2015;89:1230–41.
143. Zhu Q, Biering SB, Mirza AM, Grasseschi BA, Mahon PJ, Lee B, et al. Individual N-glycans added at intervals along the stalk of the Nipah virus G protein prevent fusion but do not block the interaction with the homologous F protein. J Virol. 2013;87:3119–29.
144. Gui L, Jurgens EM, Ebner JL, Porotto M, Moscona A, Lee KK. Electron tomography imaging of surface glycoproteins on human parainfluenza virus 3: association of receptor binding and fusion proteins before receptor engagement. mBio. 2015;6(1):e02393-14.
145. Smith EC, Popa A, Chang A, Masante C, Dutch RE. Viral entry mechanisms: the increasing diversity of paramyxovirus entry. Febs Journal. 2009;276:7217–27.
146. Bissonnette MLZ, Connolly SA, Young DF, Randall RE, Paterson RG, Lamb RA. Analysis of the pH requirement for isolates of the paramyxovirus membrane fusion of different parainfluenza virus 5. J Virol. 2006;80:3071–7.
147. Srinivasakumar N, Ogra PL, Flanagan TD. Characteristics of fusion of respiratory syncytial virus with Hep-2 cells as measured by R18 fluorescence dequenching assay. J Virol. 1991;65:4063–9.
148. San Roman K, Villar E, Munoz-Barroso I. Acidic pH enhancement of the fusion of Newcastle disease virus with cultured cells. Virology. 1999;260:329–41.
149. Herfst S, Mas V, Ver LS, Wierda RJ, Osterhaus ADME, Fouchier RAM, et al. Low-pH-induced membrane fusion mediated by human metapneumovirus F protein is a rare, strain-dependent phenomenon. J Virol. 2008;82:8891–5.
150. Seth S, Vincent A, Compans RW. Activation of fusion by the SER virus F protein: a low-pH-dependent paramyxovirus entry process. J Virol. 2003;77:6520–7.
151. Pernet O, Pohl C, Ainouze M, Kweder H, Buckland R. Nipah virus entry can occur by macropinocytosis. Virology. 2009;395:298–311.
152. Cantin C, Holguera J, Ferreira L, Villar E, Munoz-Barroso I. Newcastle disease virus may enter cells by caveolae-mediated endocytosis. J Gen Virol. 2007;88:559–69.
153. Kolokoltsov AA, Deniger D, Fleming EH, Roberts NJ, Karpilow JM, Davey RA. Small interfering RNA profiling reveals key role of clathrin-mediated endocytosis and early endosome formation for infection by respiratory syncytial virus. J Virol. 2007;81:7786–800.
154. Diederich S, Thiel L, Maisner A. Role of endocytosis and cathepsin-mediated activation in Nipah virus entry. Virology. 2008;375:391–400.
155. Andersson T, Wallen P, Grillner S, Norrby E, Kristensson K. A calcium-channel antagonist can prevent paramyxovirus-induced neurodegeneration. Neuroreport. 1991;2:145–8.
156. Haywood AM, Boyer BP. Sendai virus membrane-fusion—time course and effect of temperature, pH, calcium, and receptor concentration. Biochemistry. 1982;21:6041–6.
157. Donald JE, Zhang Y, Fiorin G, Carnevale V, Slochower DR, Gai F, et al. Transmembrane orientation and possible role of the fusogenic peptide from parainfluenza virus 5 (PIV5) in promoting fusion. Proc Natl Acad Sci U S A. 2011;108:3958–63.
158. Bissonnette MLZ, Donald JE, DeGrado WF, Jardetzky TS, Lamb RA. Functional analysis of the transmembrane domain in paramyxovirus F protein-mediated membrane fusion. J Mol Biol. 2009;386:14–36.
159. Bagai S, Lamb RA. Truncation of the COOH-terminal region of the paramyxovirus SV5 fusion protein leads to hemifusion but not complete fusion. J Cell Biol. 1996;135:73–84.
160. Dutch RE, Lamb RA. Deletion of the cytoplasmic tail of the fusion protein of the paramyxovirus simian virus 5 affects fusion pore enlargement. J Virol. 2001;75:5363–9.
161. Seth S, Vincent A, Compans RW. Mutations in the cytoplasmic domain of a paramyxovirus fusion glycoprotein rescue syncytium formation and eliminate the hemagglutinin-neuraminidase protein requirement for membrane fusion. J Virol. 2003;77:167–78.
162. Joshi SB, Dutch RE, Lamb RA. A core trimer of the paramyxovirus fusion protein: parallels to influenza virus hemagglutinin and HIV-1 gp41. Virology. 1998;248:20–34.
163. Hernandez LD, Hoffman LR, Wolfsberg TG, White JM. Virus-cell and cell-cell fusion. Annu Rev Cell Dev Biol. 1996;12:627–61.
164. Wurth MA, Schowalter RM, Smith EC, Moncman CL, Dutch RE, McCann RO. The actin cytoskeleton inhibits pore expansion during PIV5 fusion protein-promoted cell-cell fusion. Virology. 2010;404:117–26.
165. Gower TL, Peeples ME, Collins PL, Graham BS. RhoA is activated during respiratory syncytial virus infection. Virology. 2001;283:188–96.
166. Schowalter RM, Wurth MA, Aguilar HC, Lee B, Moncman CL, McCann RO, et al. Rho GTPase activity modulates paramyxovirus fusion protein-mediated cell-cell fusion. Virology. 2006;350:323–34.
167. Taylor MP, Koyuncu OO, Enquist LW. Subversion of the actin cytoskeleton during viral infection. Nat Rev Microbiol. 2011;9:427–39.
168. Kallewaard NL, Boxena AL, Crowe JE. Cooperativity of actin and microtubule elements during replication of respiratory syncytial virus. Virology. 2005;331:73–81.